CIK 0001139685 · <br>Emerging growth company
20/20 Biolabs, Inc.
Sign in to watch- Ticker
- AIDX
- Exchange
- Nasdaq
- Industry
- Services-Testing Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 522272107
- Phone
- 2404536339
- Business address
- 9430 KEY WEST AVENUE, SUITE 100, ROCKVILLE, MD, 20850
- Former names
- 20/20 GeneSystems, Inc., 20/20 GENE SYSTEMS INC
- CORRESP Other Correspondence Between Filers and SEC Staff
- 1-A/A Other 1-A/A
- C-AR-W Other C-AR-W
- C-AR Other C-AR
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 1-A/A Other 1-A/A
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 1-A/A Other 1-A/A
- UPLOAD Other SEC-generated Letter
- CORRESP Other Correspondence Between Filers and SEC Staff
- 1-A/A Other 1-A/A
- UPLOAD Other SEC-generated Letter
- 1-A Other 1-A
- C/A Other C/A
- C/A Other C/A
- C Other C
- D/A Other Amended Notice of Exempt Offering of Securities
- D Other Notice of Sales of Unregistered Securities
Page 8 of 9 · 167 filings